Identification and characterization of NPC1L1 variants in Uygur and Kazakh with extreme low-density lipoprotein cholesterol

Biochemical and Biophysical Research Communications ◽

10.1016/j.bbrc.2016.09.164 ◽

2016 ◽

Vol 479 (4) ◽

pp. 628-635 ◽

Author(s):

Qinghua Yuan ◽

Zhenyan Fu ◽

Jian Wei ◽

Pei-Shan Li ◽

Hong-Hua Miao ◽

...

Keyword(s):

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Identification And Characterization

Download Full-text

Identification and Characterization of an ACC/AHA High-Risk Population: Patients with Low Density Lipoprotein Cholesterol ≥190 mg/dl*

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2015.03.069 ◽

2015 ◽

Vol 9 (3) ◽

pp. 452

Author(s):

Erik Kelly ◽

Michael Simonson ◽

Danielle Duffy

Keyword(s):

High Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

High Risk Population ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Risk Population ◽

Identification And Characterization

Download Full-text

Development and characterization of liposomal formulation containing phytosterols and tocopherols for reducing low-density lipoprotein cholesterol.

10.3390/iecp2020-08796 ◽

2020 ◽

Author(s):

Anas El-Aneed ◽

Asmita Poudel ◽

George Gachumi ◽

Zafer Bashi ◽

Ildiko Badea

Keyword(s):

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Liposomal Formulation ◽

Low Density ◽

Low Density Lipoprotein Cholesterol

Download Full-text

Characterization of Low-Density Lipoprotein Cholesterol-Lowering Efficacy for Atorvastatin in a Population-Based DNA Biorepository

Basic & Clinical Pharmacology & Toxicology ◽

10.1111/j.1742-7843.2008.00291.x ◽

2008 ◽

Vol 103 (4) ◽

pp. 354-359 ◽

Author(s):

Russell A. Wilke ◽

Richard L. Berg ◽

James G. Linneman ◽

Chengfeng Zhao ◽

Catherine A. McCarty ◽

...

Keyword(s):

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Population Based ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Cholesterol Lowering

Download Full-text

928 The more low-density lipoprotein cholesterol decreases by statin, the more fibrous component increases in a coronary atherosclerotic plaque: a prospective randomized study with intravascular ultrasound-radiofrequency analysis

European Heart Journal ◽

10.1016/s0195-668x(03)94220-5 ◽

2003 ◽

Vol 24 (5) ◽

pp. 153

Author(s):

N KOMIYAMA

Keyword(s):

Intravascular Ultrasound ◽

Atherosclerotic Plaque ◽

Low Density Lipoprotein ◽

Randomized Study ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Prospective Randomized Study ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Coronary Atherosclerotic Plaque

Download Full-text

Empagliflozin Improves Kidney Outcomes Irrespective of Control of Blood Pressure, Low-Density Lipoprotein Cholesterol and HbA1c

10.1055/s-0039-1688342 ◽

2019 ◽

Author(s):

C Wanner ◽

M Cooper ◽

S Inzucchi ◽

B Zinman ◽

I Zwiener ◽

...

Keyword(s):

Blood Pressure ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol

Download Full-text

Low Density Lipoprotein Cholesterol and Coronary Heart Disease – Lower is Better

European Cardiology Review ◽

10.15420/ecr.2005.1c ◽

2005 ◽

Vol 1 (1) ◽

pp. 1

Author(s):

Professor Dr M Breuer Hans-Willi ◽

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol

Download Full-text

03 - A dietary exchange model to study inter-individual variation in serum low-density lipoprotein cholesterol response to dietary sa

10.26226/morressier.5beaf069e668b9000b9ad79e ◽

2018 ◽

Author(s):

rona antoni ◽

Laury Sellem ◽

Athanasios Koutsos

Keyword(s):

Individual Variation ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Exchange Model ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol

Download Full-text

Faculty Opinions recommendation of Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.10173956.10958055 ◽

2011 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Adverse Events ◽

Cardiovascular Event ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Intervention Trial ◽

Low Density Lipoprotein Cholesterol

Download Full-text

Faculty Opinions recommendation of Genetics, Lifestyle, and Low-Density Lipoprotein Cholesterol in Young and Apparently Healthy Women.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732715385.793543179 ◽

2018 ◽

Author(s):

Sergio Fazio

Keyword(s):

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Healthy Women ◽

Apparently Healthy

Download Full-text

Association of the Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Ratio and Body Mass Index with Coronary Plaque Regression

American Journal of Cardiovascular Drugs ◽

10.2165/11632520-000000000-00000 ◽

2012 ◽

Vol 12 (4) ◽

pp. 279-286

Author(s):

Shigemasa Tani ◽

Michiaki Matsumoto ◽

Yasutaka Nakamura ◽

Ken Nagao ◽

Atsushi Hirayama

Keyword(s):

Body Mass Index ◽

High Density Lipoprotein ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Coronary Plaque ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Cholesterol Ratio ◽

Plaque Regression

Download Full-text